Savara, Inc.

5.16 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Savara, Inc. stock is up 6.39% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 11 March’s closed higher than February. 100% of analysts rate it a buy.

About Savara, Inc.

Savara Inc. focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor. The company is headquartered in Austin, Texas.